IBEX Technologies Stock Forecast, Price & News

-0.02 (-6.67 %)
(As of 07/22/2021)
Today's Range
50-Day Range
52-Week Range
Volume69,500 shs
Average Volume23,547 shs
Market CapitalizationC$6.95 million
P/E Ratio4.91
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IBT News and Ratings via Email

Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter.

About IBEX Technologies

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; cartilage assays for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides services, such as filling and lyophilization for making disposable medical device components; and custom fermentation and micro dispensing of enzymes, as well as contract manufacturing. It serves manufacturers of medical devices, quality control labs, and academic research institutions. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.78 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

IBEX Technologies (CVE:IBT) Frequently Asked Questions

What stocks does MarketBeat like better than IBEX Technologies?

Wall Street analysts have given IBEX Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but IBEX Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is IBEX Technologies' next earnings date?

IBEX Technologies is scheduled to release its next quarterly earnings announcement on Thursday, September 16th 2021.
View our earnings forecast for IBEX Technologies

How has IBEX Technologies' stock been impacted by COVID-19?

IBEX Technologies' stock was trading at C$0.12 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IBT stock has increased by 133.3% and is now trading at C$0.28.
View which stocks have been most impacted by COVID-19

Who are IBEX Technologies' key executives?

IBEX Technologies' management team includes the following people:
  • Mr. Paul Baehr, Pres, CEO & Chairman (Age 78, Pay $313.6k)
  • Mahendra Kumar Pallapothu, VP of Operations
  • Belinda Franco C.A., CPA, CFO, Director of Fin. & Admin. and Sec.

Who are some of IBEX Technologies' key competitors?

What other stocks do shareholders of IBEX Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE), Bank of Montreal (BMO), Antares Pharma (ATRS), Algonquin Power & Utilities (AQN) and (AJA.AX) (AJA).

What is IBEX Technologies' stock symbol?

IBEX Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IBT."

How do I buy shares of IBEX Technologies?

Shares of IBT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is IBEX Technologies' stock price today?

One share of IBT stock can currently be purchased for approximately C$0.28.

How much money does IBEX Technologies make?

IBEX Technologies has a market capitalization of C$6.95 million and generates C$5.39 million in revenue each year.

What is IBEX Technologies' official website?

The official website for IBEX Technologies is

Where are IBEX Technologies' headquarters?

IBEX Technologies is headquartered at 5485 Pare St Suite 100, MONT-ROYAL, QC H4P 1P7, Canada.

How can I contact IBEX Technologies?

IBEX Technologies' mailing address is 5485 Pare St Suite 100, MONT-ROYAL, QC H4P 1P7, Canada. The company can be reached via phone at +1-514-3444004.

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.